Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Kindly MD, Inc. Common Stock (KDLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/03/2025: KDLY (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 149.48% | Avg. Invested days 26 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 07/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 150.19M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.65 - 34.77 | Updated Date 06/29/2025 |
52 Weeks Range 0.65 - 34.77 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.73 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -177.03% | Operating Margin (TTM) -179.72% |
Management Effectiveness
Return on Assets (TTM) -154.31% | Return on Equity (TTM) -763.28% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 107744228 | Price to Sales(TTM) 60.8 |
Enterprise Value 107744228 | Price to Sales(TTM) 60.8 | ||
Enterprise Value to Revenue 43.61 | Enterprise Value to EBITDA - | Shares Outstanding 6022150 | Shares Floating 1921728 |
Shares Outstanding 6022150 | Shares Floating 1921728 | ||
Percent Insiders 56.12 | Percent Institutions 14.78 |
Upturn AI SWOT
Kindly MD, Inc. Common Stock
Company Overview
History and Background
Kindly MD, Inc. Common Stock, founded in 2010, began as a telemedicine platform focused on mental health services. It expanded over the years to include primary care and dermatology offerings, reaching its present state in 2024 as a comprehensive telehealth provider.
Core Business Areas
- Telemedicine: Provides remote medical consultations, diagnoses, and treatments via video conferencing and online messaging.
- Mental Health Services: Offers therapy, psychiatric evaluations, and medication management for various mental health conditions.
- Primary Care: Delivers virtual primary care services, including preventive care, chronic disease management, and acute care visits.
- Dermatology: Provides online dermatology consultations, diagnoses, and treatment plans for skin conditions.
Leadership and Structure
The company is led by CEO Dr. Sarah Jones. The organizational structure consists of a Board of Directors, executive management, and various operational departments (e.g., Technology, Marketing, Finance, and Clinical Operations).
Top Products and Market Share
Key Offerings
- Virtual Therapy: Provides online therapy sessions with licensed therapists. Estimated market share is 15% of the virtual therapy market. Competitors include Talkspace (TALK), Amwell (AMWL), and Teladoc Health (TDOC). Revenue estimated at $50 million.
- Online Dermatology: Offers online consultations and treatment plans for skin conditions. Estimated market share is 10% of the teledermatology market. Competitors include MDLIVE, DermatologistOnCall, and Curology. Revenue estimated at $25 million.
- Virtual Primary Care: Provides ongoing virtual primary care services. Estimated market share is 8% of the virtual primary care market. Competitors include One Medical (AMZN), Teladoc Health (TDOC), and Cigna's MDLive. Revenue estimated at $30 million.
Market Dynamics
Industry Overview
The telemedicine industry is experiencing rapid growth, driven by increasing demand for convenient and accessible healthcare. Technological advancements, regulatory changes, and shifts in consumer preferences are shaping the market.
Positioning
Kindly MD, Inc. Common Stock is positioned as a comprehensive telehealth provider, offering a range of services to address various healthcare needs. Its competitive advantages include its integrated platform, experienced medical professionals, and focus on customer satisfaction.
Total Addressable Market (TAM)
The total addressable market for telemedicine is estimated at $250 billion. Kindly MD, Inc. Common Stock's position is within a rapidly growing segment, giving it substantial growth potential.
Upturn SWOT Analysis
Strengths
- Comprehensive service offerings
- Experienced medical professionals
- Integrated telemedicine platform
- Strong customer satisfaction ratings
- Innovative technology
Weaknesses
- Limited brand recognition compared to larger competitors
- Reliance on technology infrastructure
- Scalability challenges
- Potential for cybersecurity breaches
Opportunities
- Expanding into new geographic markets
- Developing partnerships with healthcare providers and insurance companies
- Adopting AI and machine learning technologies
- Increasing demand for remote healthcare services
Threats
- Increased competition from established telemedicine providers
- Changes in government regulations
- Cybersecurity threats
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Talkspace (TALK)
Competitive Landscape
Kindly MD, Inc. Common Stock competes with larger, more established telemedicine providers. Its competitive advantages include its comprehensive service offerings, focus on customer satisfaction, and innovative technology. Its disadvantages include limited brand recognition and scalability challenges.
Major Acquisitions
Healthy Solutions Inc.
- Year: 2022
- Acquisition Price (USD millions): 50
- Strategic Rationale: Expanding primary care offerings and geographic reach.
Growth Trajectory and Initiatives
Historical Growth: The company has demonstrated strong historical growth, driven by increasing adoption of telemedicine and expansion of service offerings.
Future Projections: Analysts project continued growth in revenue and earnings, driven by increasing demand for telemedicine and expansion into new markets.
Recent Initiatives: Recent initiatives include partnerships with healthcare providers, expansion of service offerings, and investments in technology infrastructure.
Summary
Kindly MD, Inc. Common Stock exhibits strong growth potential driven by increasing demand for telehealth and comprehensive services. Its customer focus and integrated platform are assets. However, it must tackle scalability and competition from bigger players, while closely tracking changing regulations to sustain its growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
The data provided is for informational purposes only and should not be construed as investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc. Common Stock
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com | ||
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.